Hockel Konstantin, Diedler Jennifer, Steiner Jochen, Birkenhauer Ulrich, Ernemann Ulrike, Schuhmann Martin U
Department of Neurosurgery, Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.
Department of Neurosurgery, Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.
World Neurosurg. 2017 May;101:372-378. doi: 10.1016/j.wneu.2017.02.014. Epub 2017 Feb 14.
For the treatment and prevention of delayed cerebral ischemia after subarachnoid hemorrhage, the vasodilating agent nimodipine (NDP) is widely employed. This study investigates the effect of NDP on cerebrovascular autoregulation, assessed by pressure reactivity index (PRx), and brain tissue oxygenation (pO) when given continuously intravenously as an intra-arterial bolus or during continuous intra-arterial therapy.
Computerized continuous neuromonitoring data (intracranial pressure, mean arterial pressure, cerebral perfusion pressure [CPP], pO, PRx) of 105 patients with aneurysmal SAH were retrospectively evaluated. The effect of NDP on all parameters was compared when applied intra-arterially for the treatment of severe macrovasospasm leading to perfusion deficits as either bolus treatment (n = 111 in 37 patients) or continuous infusion (n = 20 patients) to patients without or with only mild macrovasospasm who received either intravenous NDP or no NDP at all.
Compared with patients without treatment, the intravenous application of NDP was associated with a significantly higher PRx. Autoregulation was strongly and long lastingly affected (high PRx) in continuous intra-arterial NDP infusion, accompanied by a sustained improvement of pO. Intra-arterial bolus NDP application resulted as well in a significant increase of pO and PRx; the induced effect, however, was transient and subsided within 6 hours. Intracranial pressure, mean arterial pressure, and CPP were not affected during the monitoring period.
The pharmacologically induced alteration of the cerebrovascular autoregulation by NDP correlates with changes of pO and indicates a beneficial effect on cerebral blood flow if CPP is maintained. This effect is limited to a few hours after bolus treatment and milder for intravenous compared with intra-arterial application.
为治疗和预防蛛网膜下腔出血后的迟发性脑缺血,血管扩张剂尼莫地平(NDP)被广泛应用。本研究调查了NDP在以动脉内推注或持续动脉内治疗的方式持续静脉给药时,对通过压力反应性指数(PRx)评估的脑血管自动调节以及脑组织氧合(pO)的影响。
回顾性评估了105例动脉瘤性蛛网膜下腔出血患者的计算机化连续神经监测数据(颅内压、平均动脉压、脑灌注压[CPP]、pO、PRx)。将NDP应用于因严重大血管痉挛导致灌注不足的患者进行动脉内治疗时,作为推注治疗(37例患者中的111次)或持续输注(20例患者),与未发生或仅发生轻度大血管痉挛且接受静脉注射NDP或未接受任何NDP治疗的患者相比,比较NDP对所有参数的影响。
与未接受治疗的患者相比,静脉应用NDP与显著更高的PRx相关。在持续动脉内NDP输注中,自动调节受到强烈且持久的影响(高PRx),同时pO持续改善。动脉内推注NDP也导致pO和PRx显著增加;然而,诱导的效果是短暂的,在6小时内消退。在监测期间,颅内压、平均动脉压和CPP均未受到影响。
NDP通过药理学诱导的脑血管自动调节改变与pO的变化相关,并且表明如果维持CPP,对脑血流量有有益影响。这种效果在推注治疗后仅限于几个小时,并且与动脉内应用相比,静脉应用时的效果更轻。